Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
On the Frontlines of Prostate CancerEvolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
ADT Monotherapy for mHSPC: How to Identify the Right Patients
On the Frontlines of Prostate CancerADT Monotherapy for mHSPC: How to Identify the Right Patients
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
On the Frontlines of Prostate CancerRedefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Gene Therapy for Hemophilia B: Assessing Long-Term Safety and Efficacy
Clinician's RoundtableGene Therapy for Hemophilia B: Assessing Long-Term Safety and Efficacy
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerOptimizing Quality of Life in HER2+ Metastatic Breast Cancer
- 4 questions
- 3 questions
- 4 questions
- 2 questions
- 10 questions
- 4 questions
Platelet Perspectives: Analysing Phase III Data
Medical Industry FeaturePlatelet Perspectives: Analysing Phase III Data
Assessing Cutaneous Squamous Cell Carcinoma in People of Color
Medical Industry FeatureAssessing Cutaneous Squamous Cell Carcinoma in People of Color
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
Medical Industry FeatureClinical Decision Making for HER2 Low Metastatic Breast Cancer
Gene Therapy for Hemophilia B: Real-World Perspectives from an HCP and Patient
Medical Industry FeatureGene Therapy for Hemophilia B: Real-World Perspectives from an HCP and Patient
Treating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Medical Industry FeatureTreating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Frontline Consolidation in B-ALL: Expert Insights on the Role of Blinatumomab
Medical Industry FeatureFrontline Consolidation in B-ALL: Expert Insights on the Role of Blinatumomab
- 05/13/2025
- 05/12/2025
- 05/09/2025
- 05/09/2025
- 05/08/2025
- 05/08/2025
